The Clorox Company (NYSE:CLX) Shares Acquired by Verity Asset Management Inc.

Verity Asset Management Inc. grew its stake in shares of The Clorox Company (NYSE:CLX) by 86.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,869 shares of the company’s stock after acquiring an additional 1,334 shares during the period. Verity Asset Management Inc.’s holdings in Clorox were worth $467,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Insight Folios Inc boosted its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after buying an additional 63 shares during the period. Fiduciary Group LLC boosted its position in Clorox by 0.4% during the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares during the period. GHP Investment Advisors Inc. grew its stake in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after buying an additional 72 shares during the last quarter. SPC Financial Inc. increased its position in Clorox by 2.2% in the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after buying an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its position in Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.1 %

CLX opened at $162.85 on Friday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.09. The company has a market capitalization of $20.16 billion, a P/E ratio of 56.74, a P/E/G ratio of 3.02 and a beta of 0.41. The stock has a fifty day moving average of $161.89 and a 200-day moving average of $146.58. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS. On average, equities analysts expect that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is 170.04%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their price target for the company from $155.00 to $170.00 in a research report on Wednesday. Deutsche Bank Aktiengesellschaft boosted their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Citigroup upped their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $155.00.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.